HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Cazzola Selected Research

Infections

1/2024Biologics for asthma and risk of pneumonia.
1/2021Guidance on nebulization during the current COVID-19 pandemic.
10/2020Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
1/2019Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.
7/2013Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
1/2006Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
1/2004Macrolide and occult infection in asthma.
1/2002Delivering antibacterials to the lungs: considerations for optimizing outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Cazzola Research Topics

Disease

239Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 01/2003
107Asthma (Bronchial Asthma)
03/2024 - 01/2002
34Inflammation (Inflammations)
02/2024 - 01/2004
29Neoplasms (Cancer)
01/2023 - 08/2003
27Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023 - 12/2002
22Primary Myelofibrosis (Myelosclerosis)
01/2020 - 09/2004
19Pneumonia (Pneumonitis)
01/2024 - 04/2002
12Essential Thrombocythemia
01/2020 - 08/2004
11Airway Obstruction (Choking)
02/2024 - 01/2002
11COVID-19
11/2022 - 01/2020
11Dyspnea (Shortness of Breath)
11/2022 - 01/2004
11Anemia
01/2022 - 01/2004
11Iron Overload
01/2015 - 02/2002
8Infections
01/2024 - 01/2002
8Chronic Bronchitis
06/2022 - 10/2005
8Cough
01/2021 - 01/2002
8Obstructive Lung Diseases (Obstructive Lung Disease)
01/2021 - 08/2006
7Disease Progression
10/2023 - 11/2004
7Lung Diseases (Lung Disease)
07/2023 - 03/2012
7Respiratory Tract Infections (Respiratory Tract Infection)
12/2018 - 07/2003
6Bronchiectasis
12/2023 - 01/2016
6Polycythemia Vera
01/2022 - 10/2004
6Thrombosis (Thrombus)
12/2017 - 03/2002
6Refractory Anemia
04/2013 - 03/2003
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020 - 11/2004
5Heart Failure
01/2020 - 11/2005
5Leukemia
01/2020 - 12/2002
5Splenomegaly
11/2017 - 06/2011
5Cataract (Cataracts)
06/2006 - 03/2002
4Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 12/2013
4Cystic Fibrosis (Mucoviscidosis)
09/2022 - 01/2016
4Monoclonal Gammopathy of Undetermined Significance
12/2017 - 03/2013

Drug/Important Bio-Agent (IBA)

88Bronchodilator Agents (Bronchodilators)IBA
02/2024 - 01/2003
84Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024 - 07/2004
45Muscarinic AntagonistsIBA
07/2023 - 05/2009
32Tiotropium Bromide (Spiriva)FDA Link
02/2020 - 01/2004
27Formoterol Fumarate (Oxis)FDA Link
04/2021 - 01/2003
23IronIBA
01/2022 - 02/2002
16CytokinesIBA
02/2024 - 01/2004
15indacaterolIBA
10/2017 - 07/2005
14Biomarkers (Surrogate Marker)IBA
04/2024 - 11/2009
14Cholinergic Agents (Cholinergics)IBA
01/2021 - 07/2004
13Anti-Bacterial Agents (Antibiotics)IBA
12/2022 - 06/2003
13Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
11/2022 - 10/2012
13Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
04/2021 - 01/2015
12Proteins (Proteins, Gene)FDA Link
05/2023 - 02/2002
12ruxolitinibIBA
10/2020 - 06/2011
11Theophylline (Theon)FDA LinkGeneric
01/2020 - 01/2004
10GoldIBA
07/2023 - 08/2006
10Monoclonal AntibodiesIBA
07/2023 - 09/2004
10Albuterol (Salbutamol)FDA LinkGeneric
01/2021 - 01/2004
10Salmeterol Xinafoate (Serevent)FDA Link
08/2013 - 01/2004
9Adrenergic Receptors (Adrenergic Receptor)IBA
09/2023 - 01/2007
9CalreticulinIBA
01/2023 - 12/2013
9Acetylcysteine (Siran)FDA LinkGeneric
01/2021 - 03/2014
8Ferritins (Ferritin)IBA
06/2013 - 03/2003
7ensifentrineIBA
12/2023 - 11/2013
7Expectorants (Mucolytics)IBA
07/2023 - 01/2017
7erdosteineIBA
07/2023 - 01/2018
7DNA (Deoxyribonucleic Acid)IBA
11/2022 - 07/2003
7GSK573719IBA
03/2022 - 01/2013
7vilanterolIBA
03/2022 - 07/2012
7Messenger RNA (mRNA)IBA
03/2021 - 03/2002
7Oxygen (Dioxygen)IBA
01/2021 - 12/2005
7doxofyllineIBA
01/2020 - 01/2017
7Janus Kinase 2IBA
01/2016 - 11/2005
6AntioxidantsIBA
07/2023 - 01/2017
6metal transporting protein 1 (ferroportin)IBA
01/2022 - 11/2002
6HepcidinsIBA
01/2022 - 03/2004
6ElementsIBA
01/2022 - 03/2002
6Hemoglobins (Hemoglobin)IBA
01/2018 - 10/2009
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2017 - 01/2002
6ErythropoietinFDA Link
01/2017 - 08/2003
6Phosphodiesterase 4 InhibitorsIBA
08/2016 - 06/2006
6Cholinergic Antagonists (Anticholinergics)IBA
01/2016 - 06/2009
6ApoferritinsIBA
06/2006 - 03/2002
5Omalizumab (Xolair)FDA Link
02/2024 - 09/2004
5Interleukin-5 (Interleukin 5)IBA
01/2023 - 01/2018
5fluticasone furoateFDA Link
01/2023 - 02/2015
5Budesonide (Pulmicort)FDA LinkGeneric
04/2021 - 01/2006
5RoflumilastIBA
01/2018 - 02/2010
5Immunoglobulin M (IgM)IBA
12/2017 - 03/2013
5Hydroxyurea (Hydrea)FDA LinkGeneric
10/2017 - 02/2006
5aclidinium bromideIBA
01/2017 - 05/2009
5olodaterolIBA
07/2016 - 07/2012
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 05/2004
4benralizumabIBA
02/2024 - 09/2017
4SteroidsIBA
06/2023 - 08/2018
4Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2023 - 02/2010
4ChemokinesIBA
01/2023 - 09/2016
4Beclomethasone (Beclometasone)FDA Link
04/2021 - 02/2011
4reslizumabIBA
01/2019 - 09/2017
4Heme (Haem)IBA
01/2018 - 11/2002
4Interleukin-8 (Interleukin 8)IBA
01/2018 - 01/2004

Therapy/Procedure

157Therapeutics
02/2024 - 01/2002
23Nebulizers and Vaporizers (Inhaler)
01/2023 - 01/2004
15Drug Therapy (Chemotherapy)
03/2024 - 12/2002
5Biological Therapy
03/2024 - 01/2018
5Precision Medicine
11/2022 - 01/2017
5Hematopoietic Stem Cell Transplantation
10/2016 - 07/2013